(Q42985021)

12 November 2017

Japanese encephalitis vaccine (inactivated, adsorbed) [IXIARO]. (English)

1 reference

Japanese encephalitis virus

12 November 2017

0 references

Japanese encephalitis

1 reference

Japanese encephalitis vaccine

inferred from title

1 reference

1 reference

2

Greg L Plosker

1 reference

12 November 2017

Sean T Duggan

1

1 reference

12 November 2017

1 January 2009

1 reference

12 November 2017

1 reference

12 November 2017

69

1 reference

12 November 2017

1

1 reference

12 November 2017

115-122

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200969010-00008

12 November 2017

0 references

cites work

WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1-2 June 2006.

1 reference

12 December 2020

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study.

1 reference

12 December 2020

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

1 reference

12 December 2020

Pathogenic flaviviruses.

1 reference

12 December 2020

Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51.

1 reference

12 December 2020

Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study

1 reference

12 December 2020

Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004

1 reference

12 December 2020

Japanese encephalitis vaccines: current vaccines and future prospects

1 reference

12 December 2020

Development of Vero cell-derived inactivated Japanese encephalitis vaccine

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine

1 reference

12 December 2020

Anaphylaxis to Japanese encephalitis vaccine

1 reference

12 December 2020

Control of Japanese encephalitis--within our grasp?

1 reference

12 December 2020

10.2165/00003495-200969010-00008

Identifiers

DOI

1 reference

PubMed ID

19192940

Dimensions Publication ID

12 November 2017

0 references

1 reference

PubMed ID

19192940